Home | Business News | Browse by Publication | B | Biotech Business

CHDI FOUNDATION EVALUATES SIX SAMARITAN ALZHEIMER'S DRUGS.

Publication: Biotech Business
Publication Date: 01-MAR-08 		Format: Online
Delivery: Immediate Online Access

Article Excerpt
Samaritan Pharmaceuticals, Inc. (OTCBB:SPHC), a biopharmaceutical company focused on bringing innovative life-saving drugs to suffering patients, has entered into an agreement with CHDI Foundation, Inc. CHDI is a nonprofit organization pursuing the discovery and development of drugs to delay or slow the progression of Huntington's disease (HD), an inherited disorder that causes programmed degeneration of brain cells. Per the agreement, Samaritan...

Access Full Article, Compliments of Goliath

View this article FREE - Now for a Limited Time, try Goliath Business News
Free for 3 Days!



More articles from Biotech Business
CHELSEA THERAPEUTICS INITIATES PHASE II TRIAL OF CH-1504.(Medical cond..., March 01, 2008
FDA ACCEPTS AZX100 IND FOR DERMAL/HYPERTROPHIC SCARRING.(Clinical repo..., March 01, 2008

Looking for additional articles?
Search our database of over 3 million articles.

Looking for more in-depth information on this industry?
Search our complete database of Industry & Market reports by text, subject, publication name or publication date.

About Goliath
Whether you're looking for sales prospects, competitive information, company analysis or best practices in managing your organization, Goliath can help you meet your business needs.

Our extensive business information databases empower business professionals with both the breadth and depth of credible, authoritative information they need to support their business goals. Whether it be strategic planning, sales prospecting, company research or defining management best practices - Goliath is your leading source for accurate information.